Identifying	O
priorities	O
to	O
improve	O
paediatric	O
in	B:C0019994
-	I:C0019994
hospital	I:C0019994
antimicrobial	O
use	O
by	O
cross-sectional	O
evaluation	I:C0010362
of	O
prevalence	O
and	O
appropriateness	O
of	O
prescription	O
.	O

Identifying	O
priorities	O
to	O
improve	O
paediatric	O
in	O
-	I:C0019994
hospital	I:C0019994
antimicrobial	B:C1136254
use	O
by	O
cross-sectional	O
evaluation	I:C0010362
of	O
prevalence	O
and	O
appropriateness	O
of	O
prescription	O
.	O

Identifying	O
priorities	O
to	O
improve	O
paediatric	O
in	O
-	I:C0019994
hospital	I:C0019994
antimicrobial	O
use	O
by	O
cross-sectional	B:C0010362
evaluation	I:C0010362
of	O
prevalence	O
and	O
appropriateness	O
of	O
prescription	O
.	O

Identifying	O
priorities	O
to	O
improve	O
paediatric	O
in	O
-	I:C0019994
hospital	I:C0019994
antimicrobial	O
use	O
by	O
cross-sectional	O
evaluation	I:C0010362
of	O
prevalence	O
and	O
appropriateness	O
of	O
prescription	B:C0033080
.	O

Information	O
about	O
paediatric	O
in	B:C0019994
-	I:C0019994
hospital	I:C0019994
antimicrobial	O
usage	O
and	O
prescribing	O
patterns	O
to	O
guide	O
improvement	O
strategies	O
is	O
scant	O
.	O

Information	O
about	O
paediatric	O
in	O
-	I:C0019994
hospital	I:C0019994
antimicrobial	B:C1136254
usage	O
and	O
prescribing	O
patterns	O
to	O
guide	O
improvement	O
strategies	O
is	O
scant	O
.	O

We	O
aim	O
to	O
use	O
an	O
evaluation	B:C0220825
of	O
the	O
prevalence	O
and	O
appropriateness	O
of	O
antimicrobial	O
prescription	O
to	O
identify	O
antimicrobial	O
stewardship	O
priorities	O
in	O
children	O
.	O

We	O
aim	O
to	O
use	O
an	O
evaluation	O
of	O
the	O
prevalence	O
and	O
appropriateness	O
of	O
antimicrobial	B:C1136254
prescription	O
to	O
identify	O
antimicrobial	O
stewardship	O
priorities	O
in	O
children	O
.	O

We	O
aim	O
to	O
use	O
an	O
evaluation	O
of	O
the	O
prevalence	O
and	O
appropriateness	O
of	O
antimicrobial	O
prescription	B:C0033080
to	O
identify	O
antimicrobial	O
stewardship	O
priorities	O
in	O
children	O
.	O

We	O
aim	O
to	O
use	O
an	O
evaluation	O
of	O
the	O
prevalence	O
and	O
appropriateness	O
of	O
antimicrobial	O
prescription	O
to	O
identify	O
antimicrobial	B:C1136254
stewardship	O
priorities	O
in	O
children	O
.	O

A	O
cross-sectional	B:C0010362
point	I:C0010362
study	I:C0010362
was	O
performed	O
on	O
hospitalised	O
paediatric	O
patients	O
in	O
a	O
Spanish	O
tertiary	O
hospital	I:C0019994
,	O
assessing	O
the	O
prevalence	O
of	O
antimicrobial	O
prescription	O
(	O
PAP	O
)	O
and	O
appropriateness	O
of	O
antimicrobial	O
prescription	O
(	O
AAP	O
)	O
.	O

A	O
cross-sectional	O
point	I:C0010362
study	I:C0010362
was	O
performed	O
on	O
hospitalised	O
paediatric	O
patients	O
in	O
a	O
Spanish	B:C0037747
tertiary	O
hospital	I:C0019994
,	O
assessing	O
the	O
prevalence	O
of	O
antimicrobial	O
prescription	O
(	O
PAP	O
)	O
and	O
appropriateness	O
of	O
antimicrobial	O
prescription	O
(	O
AAP	O
)	O
.	O

A	O
cross-sectional	O
point	I:C0010362
study	I:C0010362
was	O
performed	O
on	O
hospitalised	O
paediatric	O
patients	O
in	O
a	O
Spanish	O
tertiary	B:C0019994
hospital	I:C0019994
,	O
assessing	O
the	O
prevalence	O
of	O
antimicrobial	O
prescription	O
(	O
PAP	O
)	O
and	O
appropriateness	O
of	O
antimicrobial	O
prescription	O
(	O
AAP	O
)	O
.	O

Evaluation	B:C0220825
was	O
performed	O
using	O
established	O
antimicrobial	O
guidelines	O
.	O

Evaluation	O
was	O
performed	O
using	O
established	O
antimicrobial	B:C1136254
guidelines	O
.	O

Evaluation	O
was	O
performed	O
using	O
established	O
antimicrobial	O
guidelines	B:C0162791
.	O

Other	O
factors	O
that	O
may	O
have	O
a	O
bearing	O
on	O
antimicrobial	B:C1136254
prescription	O
were	O
also	O
analysed	O
.	O

Other	O
factors	O
that	O
may	O
have	O
a	O
bearing	O
on	O
antimicrobial	O
prescription	B:C0033080
were	O
also	O
analysed	O
.	O

Other	O
factors	O
that	O
may	O
have	O
a	O
bearing	O
on	O
antimicrobial	O
prescription	O
were	O
also	O
analysed	B:C0936012
.	O

The	O
most	O
common	O
indications	O
for	O
antimicrobial	B:C1136254
use	O
were	O
antimicrobial	O
prophylaxis	O
(	O
28.3	O
%	O
,	O
32/113	O
)	O
and	O
pneumonia	O
(	O
8.2	O
%	O
,	O
8/113	O
)	O
.	O

The	O
most	O
common	O
indications	O
for	O
antimicrobial	O
use	O
were	O
antimicrobial	B:C1136254
prophylaxis	O
(	O
28.3	O
%	O
,	O
32/113	O
)	O
and	O
pneumonia	O
(	O
8.2	O
%	O
,	O
8/113	O
)	O
.	O

The	O
most	O
common	O
indications	O
for	O
antimicrobial	O
use	O
were	O
antimicrobial	O
prophylaxis	B:C3853787
(	O
28.3	O
%	O
,	O
32/113	O
)	O
and	O
pneumonia	O
(	O
8.2	O
%	O
,	O
8/113	O
)	O
.	O

The	O
most	O
common	O
indications	O
for	O
antimicrobial	O
use	O
were	O
antimicrobial	O
prophylaxis	O
(	O
28.3	O
%	O
,	O
32/113	O
)	O
and	O
pneumonia	B:C0032285
(	O
8.2	O
%	O
,	O
8/113	O
)	O
.	O

Overall	O
,	O
161	O
antimicrobials	B:C1136254
were	O
prescribed	O
(	O
1.9	O
antimicrobials	O
per	O
patient	O
)	O
:	O
55.3	O
%	O
(	O
89/161	O
)	O
were	O
empiric	O
,	O
16.1	O
%	O
(	O
26/161	O
)	O
were	O
targeted	O
and	O
28.6	O
%	O
(	O
46/161	O
)	O
were	O
prophylactic	O
.	O

Overall	O
,	O
161	O
antimicrobials	O
were	O
prescribed	O
(	O
1.9	O
antimicrobials	B:C1136254
per	O
patient	O
)	O
:	O
55.3	O
%	O
(	O
89/161	O
)	O
were	O
empiric	O
,	O
16.1	O
%	O
(	O
26/161	O
)	O
were	O
targeted	O
and	O
28.6	O
%	O
(	O
46/161	O
)	O
were	O
prophylactic	O
.	O

Amoxicillin	B:C0054066
/	I:C0054066
clavulanate	I:C0054066
(	O
8.2	O
%	O
,	O
14/171	O
)	O
and	O
sulfamethoxazole	O
/	I:C0041044
trimethoprim	I:C0041044
(	O
8.2	O
%	O
,	O
14/171	O
)	O
were	O
the	O
most	O
prescribed	O
antimicrobials	O
.	O

Amoxicillin	O
/	I:C0054066
clavulanate	I:C0054066
(	O
8.2	O
%	O
,	O
14/171	O
)	O
and	O
sulfamethoxazole	B:C0041044
/	I:C0041044
trimethoprim	I:C0041044
(	O
8.2	O
%	O
,	O
14/171	O
)	O
were	O
the	O
most	O
prescribed	O
antimicrobials	O
.	O

Amoxicillin	O
/	I:C0054066
clavulanate	I:C0054066
(	O
8.2	O
%	O
,	O
14/171	O
)	O
and	O
sulfamethoxazole	O
/	I:C0041044
trimethoprim	I:C0041044
(	O
8.2	O
%	O
,	O
14/171	O
)	O
were	O
the	O
most	O
prescribed	O
antimicrobials	B:C1136254
.	O

The	O
prescription	B:C0033080
of	O
antifungals	O
(	O
11.7	O
%	O
,	O
20/171	O
)	O
and	O
antivirals	O
(	O
1.8	O
%	O
,	O
3/171	O
)	O
was	O
analysed	O
.	O

The	O
prescription	O
of	O
antifungals	B:C0003308
(	O
11.7	O
%	O
,	O
20/171	O
)	O
and	O
antivirals	O
(	O
1.8	O
%	O
,	O
3/171	O
)	O
was	O
analysed	O
.	O

The	O
prescription	O
of	O
antifungals	O
(	O
11.7	O
%	O
,	O
20/171	O
)	O
and	O
antivirals	B:C0003451
(	O
1.8	O
%	O
,	O
3/171	O
)	O
was	O
analysed	O
.	O

The	O
prescription	O
of	O
antifungals	O
(	O
11.7	O
%	O
,	O
20/171	O
)	O
and	O
antivirals	O
(	O
1.8	O
%	O
,	O
3/171	O
)	O
was	O
analysed	B:C0936012
.	O

Major	O
causes	O
of	O
inappropriate	O
antibiotic	B:C0003232
use	O
were	O
prolonged	O
prescriptions	O
(	O
21.7	O
%	O
,	O
35/161	O
)	O
and	O
use	O
of	O
agents	O
with	O
an	O
excessively	O
broad	O
coverage	O
spectrum	O
(	O
21.1	O
%	O
,	O
34/161	O
)	O
.	O

Major	O
causes	O
of	O
inappropriate	O
antibiotic	O
use	O
were	O
prolonged	O
prescriptions	B:C0033080
(	O
21.7	O
%	O
,	O
35/161	O
)	O
and	O
use	O
of	O
agents	O
with	O
an	O
excessively	O
broad	O
coverage	O
spectrum	O
(	O
21.1	O
%	O
,	O
34/161	O
)	O
.	O

Major	O
causes	O
of	O
inappropriate	O
antibiotic	O
use	O
were	O
prolonged	O
prescriptions	O
(	O
21.7	O
%	O
,	O
35/161	O
)	O
and	O
use	O
of	O
agents	B:C1254351
with	O
an	O
excessively	O
broad	O
coverage	O
spectrum	O
(	O
21.1	O
%	O
,	O
34/161	O
)	O
.	O

PAP	O
and	O
AAP	O
varied	O
between	O
wards	B:C1305702
and	O
antimicrobials	O
.	O

PAP	O
and	O
AAP	O
varied	O
between	O
wards	O
and	O
antimicrobials	B:C1136254
.	O

Measurement	O
of	O
PAP	O
and	O
AAP	O
offers	O
valuable	O
information	O
for	O
detecting	O
priorities	O
in	O
hospital	B:C0019994
settings	I:C0019994
and	O
monitoring	O
antimicrobial	O
usage	O
prior	O
to	O
the	O
development	O
of	O
antimicrobial	O
stewardship	O
programmes	O
.	O

Measurement	O
of	O
PAP	O
and	O
AAP	O
offers	O
valuable	O
information	O
for	O
detecting	O
priorities	O
in	O
hospital	O
settings	I:C0019994
and	O
monitoring	B:C1283169
antimicrobial	O
usage	O
prior	O
to	O
the	O
development	O
of	O
antimicrobial	O
stewardship	O
programmes	O
.	O

Measurement	O
of	O
PAP	O
and	O
AAP	O
offers	O
valuable	O
information	O
for	O
detecting	O
priorities	O
in	O
hospital	O
settings	I:C0019994
and	O
monitoring	O
antimicrobial	B:C1136254
usage	O
prior	O
to	O
the	O
development	O
of	O
antimicrobial	O
stewardship	O
programmes	O
.	O

Measurement	O
of	O
PAP	O
and	O
AAP	O
offers	O
valuable	O
information	O
for	O
detecting	O
priorities	O
in	O
hospital	O
settings	I:C0019994
and	O
monitoring	O
antimicrobial	O
usage	O
prior	O
to	O
the	O
development	O
of	O
antimicrobial	B:C1136254
stewardship	O
programmes	O
.	O

In	O
our	O
setting	O
,	O
the	O
main	O
areas	O
for	O
improvement	O
are	O
duration	O
of	O
therapy	B:C0087111
and	O
proper	O
use	O
of	O
broad	O
-	I:C1136254
spectrum	I:C1136254
antimicrobials	I:C1136254
.	O

In	O
our	O
setting	O
,	O
the	O
main	O
areas	O
for	O
improvement	O
are	O
duration	O
of	O
therapy	O
and	O
proper	O
use	O
of	O
broad	B:C1136254
-	I:C1136254
spectrum	I:C1136254
antimicrobials	I:C1136254
.	O

